2BBBullish & Bearish
Oramed Pharmaceuticals Inc. (ORMP) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 16 out of 100.
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
Oramed Pharmaceuticals Inc.’s current 2BB score is 16 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 8 | Very Low |
| Momentum | 55 | Stable |
| Financial strength | 77 | Strong |
| Quality | 40 | Normal |
| Risk | 25 | Low |
| CEO | Nadav Kidron |
| Founded | 2006 |
| Employees | 13 |
| P/E ratio | 1.00 |
| 52-week range | $2.09 – $5.47 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-24 | — | 0.3774 | — | $0.00 |
| 2026-11-11 | — | 0.4386 | — | $0.00 |
| 2026-08-12 | — | 0.4386 | — | $0.00 |
| 2026-03-26 | 0.2447 | 0.0 | $0.00 | $0.00 |